We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Upon successful completion of this activity, ...

After a median 9.6 months of cabozantinib treatment, the 6-month brain metastasis progression-free rate was 56%, meeting the study’s primary endpoint.

The majority of patients who survive a stroke usually continue to suffer from permanent motor disorders (hemiparesis) or a linguistic handicap (aphasia). A new study reveals an improvement in the ...

The case: A 53-year-old right-handed woman reported 2 years of gait difficulties and progressive clumsiness and weakness of her right upper and lower extremities. She was referred to our neurology ...

Targeting the dentate nucleus with deep brain stimulation (DBS) was safe and feasible for promoting post-stroke rehabilitation in a first-in-human study at Cleveland Clinic. Treatment response in the ...